bluebird bio   Report issue

For profit Phase 1 Phase 3
Founded: Cambridge MA United States (1992)

Organization Overview

First Clinical Trial
2013
NCT02151526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

bluebird bio | bluebird bio, Inc.